Encompass Health (Encompass Health) ROCE %

: 14.83% (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Encompass Health's annualized ROCE % for the quarter that ended in Dec. 2023 was 14.83%.

Encompass Health ROCE % Historical Data

The historical data trend for Encompass Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encompass Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

14.64

9.68

11.30

11.21

14.29

Encompass Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																15.18	14.30	14.48	13.74	14.83

Encompass Health ROCE % Calculation

Encompass Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	750.7	/	( ( (5636.5 - 575.9)	+	(6102.4 - 656.4) )	/ 2 )
	=	750.7	/	( (5060.6	+	5446)	/ 2 )
	=	750.7	/	5253.3
	=	14.29 %

Encompass Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	798.8	/	( ( (5964.3 - 639.2)	+	(6102.4 - 656.4) )	/ 2 )
	=	798.8	/	( ( 5325.1	+	5446 )	/ 2 )
	=	798.8	/	5385.55
	=	14.83 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Encompass Health (NYSE:EHC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Encompass Health ROCE % Related Terms

Thank you for viewing the detailed overview of Encompass Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Encompass Health (Encompass Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HSOA:Germany

Address

9001 Liberty Parkway, Birmingham, AL, USA, 35242

Website

https://www.encompasshealth.com

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Executives

Douglas E Coltharp	officer: EVP, Chief Financial Officer	C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau	officer: Chief Medical Officer	24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
Mark J Tarr	officer: Executive VP Operations	C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Greg D Carmichael	director
Kevin J. O'connor	director	13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams	director	7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Andrew L Price	officer: Interim Chief Accting Officer	3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Barbara Ann Jacobsmeyer	officer: EVP, Operations	2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll	director	C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock	officer: CEO and President, Encompass	3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr	director	1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland	director	7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl	director	C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Cheryl B. Levy	officer: Chief Human Resources Officer	3137 BROOK HIGHLAND DRIVE, BIRMINGHAM AL 35242